We are reporting the worldwide experience in closing atrial septal defects (ASDs) in children
and adults using the Amplatzer Septal Occluder (ASO) as of July 2000. The outcome …

OBJECTIVE To assess the efficacy and complications of device occlusion of atrial septal
defects in adults, using the Amplatzer septal occluder (ASO). DESIGN A prospective …

Transcatheter closure of atrial septal defects (ASDs) was performed mainly in children and
adolescents. Information about outcome and complications in adults was limited. From …

Our study reports the results of a comparison of closure of atrial septal defect (ASD)
surgically with transcatheter closure using the Amplatzer septal occluder. Patients having an …

The Amplatzer septal occluder (ASO) is used for transcatheter closure of atrial septal defects
(ASDs). This study aimed to determine the factors influencing successful closure with the …

The first attempt at transcatheter closure of an atrial septal defect (ASD) was reported in
1976. 1 Since then, few devices have been evaluated in children and adults with variable …

The impact of device size choice on closure results was analyzed in 138 (101 females, 37
males; age 0.5–84.0 years) consecutive patients who underwent transcatheter closure of the …

The objective of this study was to determine the initial safety and results of unrestricted multi-
institution routine community use of the Amplatzer Septal Occluder (ASO) for atrial septal …

Aims: To analyze the efficacy and follow‐up results of percutaneous closure of Atrial septal
defect (ASD) with the Amplatzer® septal occluder in children aged< 10 years old. Methods …

BACKGROUND: The Amplatzer Septal Occluder (ASO)(AGA Medical Corp, Golden Valley,
Minn) has gained wide acceptance for transcatheter closure of atrial septal defect (ASD). We …